RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients

National Library of Medicine (brackets, no "et al."): Fahrig R, Quietzsch D, Heinrich J-C, Heinemann V, Boeck S, Schmid RM, Praha C, Liebert A, Sonntag D, Krupitza G, Hänel M. RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients. Anti-Cancer Drugs. 2006;17(9):1045 - 1056.
National Library of Medicine (grant proposals with PMCID/PMID): Fahrig R, Quietzsch D, Heinrich J-C, Heinemann V, Boeck S, Schmid RM, Praha C, Liebert A, Sonntag D, Krupitza G, Hänel M. RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients. Anti-Cancer Drugs. 2006;17(9):1045 - 1056.
National Library of Medicine (NLM) - Grant with PMID: Fahrig R, Quietzsch D, Heinrich J-C, Heinemann V, Boeck S, Schmid RM, Praha C, Liebert A, Sonntag D, Krupitza G, Hänel M. RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients. Anti-Cancer Drugs. 2006;17(9):1045 - 1056.
12,444 times
No files have yet been downloaded.
(1)
Share